Background: Right-sided heart failure after left ventricular assist device (LVAD) implantation carries high morbidity. We sought to develop a technique for expedient short-term right ventricular (RV) support with the cardiopulmonary bypass (CPB) circuit already in use during the LVAD implantation procedure.
Methods: Patients at high risk for RV failure during LVAD implantation were supported by a modified CPB circuit. A standard CPB circuit was modified to include a series of 4 wye (Y) bridge connections, allowing the ability to exclude the venous reservoir and oxygenator and to flow venous blood or arterialized blood in the same CPB outflow line.
Results: From 2019 to 2022 at a single institution, 6 patients were identified as high risk for early RV failure. Preoperative mean clinical values included central venous pressure of 16.3 ± 3.2 mm Hg, pulmonary capillary wedge pressure of 26.7 ± 3.2 mm Hg, tricuspid annular plane systolic excursion of 1.2 ± 0.23 cm, RV stroke work index of 311.7 ± 32.5, and central venous pressure/pulmonary capillary wedge pressure of 0.61 ± 0.10. All 6 patients were successfully weaned from CPB to LVAD support without the need for RV support at the conclusion of the implantation procedure.
Conclusions: We describe a configuration that supports the right ventricle during the critical period after CPB when it is at high risk of failure while the patient is being resuscitated with transfusions and volume. This technique provides flexibility in the management of complex, critically ill patients with RV failure, increasing the possibility of intraoperative RV recovery and successful separation from CPB during LVAD implantation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11708744 | PMC |
http://dx.doi.org/10.1016/j.atssr.2023.11.006 | DOI Listing |
Surg Pract Sci
June 2024
Baylor Scott and White, The Heart Hospital, 4708 Alliance Blvd, Suite 540, Plano, TX, United States.
Introduction: Although left ventricular assist device (LVAD) implantation is associated with improved survival in patients with end-stage heart failure, the impact of preoperative pulmonary function on short-term outcomes is unclear.
Methods: We conducted a retrospective review of all primary LVAD implants at a single institution. Common measures of preoperative pulmonary function were evaluated.
Front Surg
January 2025
Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
We report a case of a patient with dilated cardiomyopathy who experienced recurrent ventricular tachycardia (VT) and multiple defibrillations following CRT-D implantation. Due to worsening cardiac function, the patient required surgical implantation of a left ventricular assist device (LVAD) as a bridge to heart transplantation. During the procedure, we used the Ensite three-dimensional mapping system to perform activation and substrate mapping of the VT targets, followed by endocardial and epicardial cryoballoon ablation of clinical VT.
View Article and Find Full Text PDFESC Heart Fail
January 2025
Division of Cardiology, Department of Medicine, Hospital of the University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Aims: Right ventricular (RV) failure (RVF) after left ventricular assist device (LVAD) implant is an important cause of morbidity and mortality. Modern, data-driven approaches for defining and predicting RVF have been under-utilized.
Methods: Two hundred thirty-two patients were identified with a mean age of 55 years; 40 (17%) were women, 132 were (59%) Caucasian and 74 (32%) were Black.
JACC Case Rep
December 2024
Department of Cardiology, Medipol University Faculty of Medicine, Istanbul, Turkey.
Cardiac hemangiomas are exceedingly rare, comprising only 5% to 10% of benign cardiac tumors. We report a patient with a large right atrial mass and end-stage heart failure with severe left ventricular dysfunction. Echocardiography revealed a mass obstructing tricuspid inflow.
View Article and Find Full Text PDFWorld J Pediatr Congenit Heart Surg
January 2025
The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Background: With an increasing number of Fontan patients surviving into adulthood, the burden of end-stage heart failure is increasing. Prior studies have reported suboptimal heart transplantation (HTx) outcomes. Therefore, the authors describe their institutional experience of HTx in patients with Fontan circulation failure, including heart-liver transplantation (HLTx) and pretransplant systemic ventricular assist device (SVAD) therapies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!